STK11 Sequencing and Deletion/Duplication
Use
This test is used to identify individuals with autosomal dominant Peutz‑Jeghers syndrome (PJS) by detecting single‑nucleotide variants, deletions, and duplications in the STK11 gene, which encodes the serine/threonine‑protein kinase STK11 protein. It may be appropriate for individuals presenting with multiple hamartomatous gastrointestinal polyps, mucocutaneous hyperpigmentation in areas such as the mouth, lips, nose, eyes, genitalia, or fingers, or a family history of PJS. Genetic counseling and informed consent are strongly recommended for appropriate clinical interpretation and patient management.
Special Instructions
Not provided.
Limitations
Turnaround may be affected by incomplete orders or insurance preauthorization delays. Negative results do not rule out PJS; some variants may not be detected due to technical limitations. Variant interpretation is based on current knowledge and may change; regular re‑evaluation via VariantIQ is advised. For known familial variants, a single‑site test may be more appropriate.
Methodology
NGS
Biomarkers
STK11
Gene
Result Turnaround Time
14-21 days
Related Documents
For more information, please review the documents below
Specimen
Other
Volume
Not provided
Minimum Volume
Not provided
